Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

BACKGROUND: The optimal definitive chemotherapy regimen during concurrent chemoradiotherapy (CRT) for patients with advanced esophageal squamous cell carcinoma (ESCC) remains unclear because of conflicting evidence. This study aimed to compare the effectiveness of taxane‐based chemotherapy with that...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Jason Chia‐Hsun, Chiang, Pin‐Chun, Hung, Tsung‐Min, Chao, Yin‐Kai, Kuo, Yung‐Chia, Wen, Chih‐Tsung, Su, Po‐Jung, Peng, Meng‐Ting, Chen, Huan‐Wu, Liu, Hui‐Ling, Chang, Hsien‐Kun, Wu, Min‐Hsien, Wang, Hung‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633257/
https://www.ncbi.nlm.nih.gov/pubmed/34706159
http://dx.doi.org/10.1002/cam4.4025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633257/
https://www.ncbi.nlm.nih.gov/pubmed/34706159
http://dx.doi.org/10.1002/cam4.4025

Ejemplares similares